The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

ludc webb

Hanna Markstad

Doctoral student

ludc webb

Diagnosis and treatment of the rare procedural complication of malpositioned pacing leads in the left heart: a single center experience

Author

  • Rasmus Borgquist
  • Maiwand Farouq
  • Hanna Markstad
  • Johan Brandt
  • David Mortsell
  • Steen Jensen
  • Uzma Chaudhry
  • Lingwei Wang

Summary, in English

Objectives. This study assessed the management approach and outcome of the pacemaker or implantable cardioverter-defibrillator (ICD) leads malpositioned in the left heart. Malpositioned leads (MPLs) may have deleterious consequences, and appropriate management remains uncertain. Methods. The study population included all patients referred to a single institution for MPL in the left side of the heart after pacemaker or ICD implantation during the period from 2015 to 2021. The approach and outcome of lead management were retrospectively assessed. Results. During the study period, 6887 patients underwent device implantation. MPL was diagnosed in five patients (0.07%). In four cases, the pacing lead was placed in a coronary sinus (CS) branch, while the pacing lead was inside the left ventricle (LV) in one case. Symptoms suggestive of lead malposition were reported by 2 patients (40%). One of the patients presented with recurrent TIAs. Another presented with inappropriate ICD shocks. In one asymptomatic case, an ICD lead changed position from the right ventricle to the CS, suggesting idiopathic lead migration. In 4/5 patients, the leads were removed or repositioned by percutaneous approach, with no major periprocedural complications. Conclusions. In this series of MPL in the left heart, two patients presented with thromboembolic events or inappropriate ICD shocks. These serious complications highlight the critical need for early correct diagnosis and proper management of MPL.

Department/s

  • Arrhytmias and Cardiac Device treatment
  • Clinical studies af Atrial Fibrillation
  • Electrocardiology Research Group - CIEL
  • Cardiology
  • Cardiovascular Research - Translational Studies
  • EXODIAB: Excellence of Diabetes Research in Sweden
  • Cardiovascular Research - Epidemiology
  • Thoracic Surgery

Publishing year

2022

Language

English

Pages

302-309

Publication/Series

Scandinavian Cardiovascular Journal

Volume

56

Issue

1

Document type

Journal article

Publisher

Taylor & Francis

Topic

  • Cardiac and Cardiovascular Systems

Status

Published

Research group

  • Arrhytmias and Cardiac Device treatment
  • Clinical studies af Atrial Fibrillation
  • Electrocardiology Research Group - CIEL
  • Cardiovascular Research - Translational Studies
  • Cardiovascular Research - Epidemiology

ISBN/ISSN/Other

  • ISSN: 1651-2006